Vanessa E. Gonzalez
Impact in
- Oncology top 0.2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 32
- CAR-T cell therapy research 32
-
- Immune Cell Function and Interaction 5
- Immunotherapy and Immune Responses 3
- Co-authors
- Carl H. June (11 shared papers)Simon Francis Lacey (9 shared papers)Bruce L. Levine (7 shared papers)Jan Joseph Melenhorst (8 shared papers)Anne Chew (6 shared papers)Noelle V. Frey (5 shared papers)Stephan A. Grupp (5 shared papers)Pamela A. Shaw (5 shared papers)
- Journals
- Blood (7 papers)Nature Medicine (5 papers)Molecular Therapy (3 papers)Cell Reports Medicine (2 papers)Nature Biomedical Engineering (2 papers)
- Partner nations
- United StatesSwitzerlandDenmark
In The Last Decade
Vanessa E. Gonzalez
36 papers receiving 9.8k citations
Vanessa E. Gonzalez's Hit Papers
Peers
Comparison fields: 5 of 107
- Oncology 8.2k
- Immunology 2.7k
- Genetics 2.2k
- Hematology 658
- Biomedical Engineering 2.0k
Countries citing papers authored by Vanessa E. Gonzalez
This map shows the geographic impact of Vanessa E. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa E. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa E. Gonzalez more than expected).
Fields of papers citing papers by Vanessa E. Gonzalez
This network shows the impact of papers produced by Vanessa E. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa E. Gonzalez. The network helps show where Vanessa E. Gonzalez may publish in the future.
Co-authors
The 25 scholars most cited alongside Vanessa E. Gonzalez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Hit paper breakdown → | 2014 | 4551 |
| 2 | Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia Hit paper breakdown → | 2015 | 1482 |
| 3 | CRISPR-engineered T cells in patients with refractory cancer Hit paper breakdown → | 2020 | 1170 |
| 4 | Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia Hit paper breakdown → | 2016 | 941 |
| 5 | PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial Hit paper breakdown → | 2022 | 431 |
| 6 | 2016 | 429 | |
| 7 | Intrathecal bivalent CAR T cells targeting EGFR and IL13Rα2 in recurrent glioblastoma: phase 1 trial interim results Hit paper breakdown → | 2024 | 263 |
| 8 | 2017 | 104 | |
| 9 | 2023 | 77 | |
| 10 | Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure Hit paper breakdown → | 2025 | 72 |
| 11 | 2023 | 71 | |
| 12 | 2016 | 67 | |
| 13 | 2022 | 64 | |
| 14 | 2022 | 57 | |
| 15 | Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies Hit paper breakdown → | 2025 | 51 |
| 16 | 2020 | 49 | |
| 17 | Intracerebroventricular bivalent CAR T cells targeting EGFR and IL-13Rα2 in recurrent glioblastoma: a phase 1 trial Hit paper breakdown → | 2025 | 44 |
| 18 | 2018 | 36 | |
| 19 | 2016 | 30 | |
| 20 | 2024 | 16 |
About Vanessa E. Gonzalez
Vanessa E. Gonzalez is a scholar working on Oncology, Immunology, Genetics, Hematology and Molecular Biology, having authored 38 papers that have together received 10.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (32 papers), Virus-based gene therapy research (6 papers), CRISPR and Genetic Engineering (5 papers), Immune Cell Function and Interaction (5 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Immunotherapy and Immune Responses (3 papers), Nanowire Synthesis and Applications (3 papers) and Advancements in Semiconductor Devices and Circuit Design (2 papers). The work is most often cited by research in Oncology (8.2k citations), Immunology (2.7k citations), Genetics (2.2k citations), Hematology (658 citations) and Biomedical Engineering (2.0k citations). Vanessa E. Gonzalez has collaborated with scholars based in United States, Switzerland and Denmark. Frequent co-authors include Carl H. June, Simon Francis Lacey, Bruce L. Levine, Jan Joseph Melenhorst, Anne Chew, Noelle V. Frey, Stephan A. Grupp, Pamela A. Shaw, Zhaohui Zheng and Angela Shen. Their work appears in journals such as Blood, Nature Medicine, Molecular Therapy, Cell Reports Medicine and Nature Biomedical Engineering.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.